{"id":13728,"date":"2018-01-05T11:41:33","date_gmt":"2018-01-05T11:41:33","guid":{"rendered":"https:\/\/celonpharma.com\/?p=13728"},"modified":"2022-10-19T14:47:27","modified_gmt":"2022-10-19T14:47:27","slug":"faind","status":"publish","type":"post","link":"https:\/\/celonpharma.com\/en\/faind\/","title":{"rendered":"FAIND"},"content":{"rendered":"<div class=\"text-center\"><img loading=\"lazy\" decoding=\"async\" class=\"wp-image-26368 size-large aligncenter\" src=\"https:\/\/celonpharma.com\/wp-content\/uploads\/2022\/10\/1178-106-max-1024x92.png\" alt=\"\" width=\"1024\" height=\"92\" srcset=\"https:\/\/celonpharma.com\/wp-content\/uploads\/2022\/10\/1178-106-max-1024x92.png 1024w, https:\/\/celonpharma.com\/wp-content\/uploads\/2022\/10\/1178-106-max-300x27.png 300w, https:\/\/celonpharma.com\/wp-content\/uploads\/2022\/10\/1178-106-max-768x69.png 768w, https:\/\/celonpharma.com\/wp-content\/uploads\/2022\/10\/1178-106-max.png 1178w\" sizes=\"auto, (max-width: 1024px) 100vw, 1024px\" \/><\/div>\n<h2><strong>FAIND \u2013 A new diabetes treatment using an innovative FGF1 protein analogue.<\/strong><\/h2>\n<p><!--more--><\/p>\n<p>Diabetes is one of the most common and serious diseases of affluence in the modern society. The number of patients developing this conditions is constantly growing and diabetes complications pose a serious threat to their health and life. The project aims at developing an innovative and original anti-diabetic medication based on FGF1 protein analogue (Fibroblast Growth Factor), with properties make it an alternative therapy for patients suffering from type 2 diabetes.<br \/>\nIn the framework of the project we will conduct research on the structure of innovative proteins, test them in both vitro and in vivo as well as production and characterisation of proteins. Such procedures will allow us to select a candidate for toxicological tests and phase 1 clinical trials as well as to design the process of industrial production and prepare CTA documentation. The result will be development and marketing of an original FGF1 protein analogue used in treatment of diabetes.<\/p>\n<p>The project has been carried out by Celon Pharma in a scientific-business consortium with the University of Wroc\u0142aw.<\/p>\n<p><strong>Total value of the project amounts to<\/strong> PLN 13 396\u00a0154,28\u00a0<strong> , while the total value of funding under Smart Growth Operational Programme Measure <\/strong> 9\u00a0941\u00a0542,38\u00a0 z\u0142 w ramach POIR 4.1.4.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>FAIND \u2013 A new diabetes treatment using an innovative FGF1 protein analogue.<\/p>\n","protected":false},"author":11,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[98],"tags":[],"class_list":["post-13728","post","type-post","status-publish","format-standard","hentry","category-ue-co-financed-projects-implemented"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.0 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>FAIND - Celon Pharma<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/celonpharma.com\/en\/faind\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"FAIND - Celon Pharma\" \/>\n<meta property=\"og:description\" content=\"FAIND \u2013 A new diabetes treatment using an innovative FGF1 protein analogue.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/celonpharma.com\/en\/faind\/\" \/>\n<meta property=\"og:site_name\" content=\"Celon Pharma\" \/>\n<meta property=\"article:published_time\" content=\"2018-01-05T11:41:33+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2022-10-19T14:47:27+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/celonpharma.com\/wp-content\/uploads\/2022\/10\/1178-106-max-1024x92.png\" \/>\n<meta name=\"author\" content=\"S\u0142awomir Ni\u017cnik\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"S\u0142awomir Ni\u017cnik\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/faind\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/faind\\\/\"},\"author\":{\"name\":\"S\u0142awomir Ni\u017cnik\",\"@id\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/#\\\/schema\\\/person\\\/44c54386ed112173d6e8bcbeb6425338\"},\"headline\":\"FAIND\",\"datePublished\":\"2018-01-05T11:41:33+00:00\",\"dateModified\":\"2022-10-19T14:47:27+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/faind\\\/\"},\"wordCount\":205,\"image\":{\"@id\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/faind\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/celonpharma.com\\\/wp-content\\\/uploads\\\/2022\\\/10\\\/1178-106-max-1024x92.png\",\"articleSection\":[\"UE - co-financed projects implemented\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/faind\\\/\",\"url\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/faind\\\/\",\"name\":\"FAIND - Celon Pharma\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/faind\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/faind\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/celonpharma.com\\\/wp-content\\\/uploads\\\/2022\\\/10\\\/1178-106-max-1024x92.png\",\"datePublished\":\"2018-01-05T11:41:33+00:00\",\"dateModified\":\"2022-10-19T14:47:27+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/#\\\/schema\\\/person\\\/44c54386ed112173d6e8bcbeb6425338\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/faind\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/celonpharma.com\\\/en\\\/faind\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/faind\\\/#primaryimage\",\"url\":\"https:\\\/\\\/celonpharma.com\\\/wp-content\\\/uploads\\\/2022\\\/10\\\/1178-106-max-1024x92.png\",\"contentUrl\":\"https:\\\/\\\/celonpharma.com\\\/wp-content\\\/uploads\\\/2022\\\/10\\\/1178-106-max-1024x92.png\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/faind\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"FAIND\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/\",\"name\":\"Celon Pharma\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/#\\\/schema\\\/person\\\/44c54386ed112173d6e8bcbeb6425338\",\"name\":\"S\u0142awomir Ni\u017cnik\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"FAIND - Celon Pharma","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/celonpharma.com\/en\/faind\/","og_locale":"en_US","og_type":"article","og_title":"FAIND - Celon Pharma","og_description":"FAIND \u2013 A new diabetes treatment using an innovative FGF1 protein analogue.","og_url":"https:\/\/celonpharma.com\/en\/faind\/","og_site_name":"Celon Pharma","article_published_time":"2018-01-05T11:41:33+00:00","article_modified_time":"2022-10-19T14:47:27+00:00","og_image":[{"url":"https:\/\/celonpharma.com\/wp-content\/uploads\/2022\/10\/1178-106-max-1024x92.png","type":"","width":"","height":""}],"author":"S\u0142awomir Ni\u017cnik","twitter_card":"summary_large_image","twitter_misc":{"Written by":"S\u0142awomir Ni\u017cnik","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/celonpharma.com\/en\/faind\/#article","isPartOf":{"@id":"https:\/\/celonpharma.com\/en\/faind\/"},"author":{"name":"S\u0142awomir Ni\u017cnik","@id":"https:\/\/celonpharma.com\/en\/#\/schema\/person\/44c54386ed112173d6e8bcbeb6425338"},"headline":"FAIND","datePublished":"2018-01-05T11:41:33+00:00","dateModified":"2022-10-19T14:47:27+00:00","mainEntityOfPage":{"@id":"https:\/\/celonpharma.com\/en\/faind\/"},"wordCount":205,"image":{"@id":"https:\/\/celonpharma.com\/en\/faind\/#primaryimage"},"thumbnailUrl":"https:\/\/celonpharma.com\/wp-content\/uploads\/2022\/10\/1178-106-max-1024x92.png","articleSection":["UE - co-financed projects implemented"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/celonpharma.com\/en\/faind\/","url":"https:\/\/celonpharma.com\/en\/faind\/","name":"FAIND - Celon Pharma","isPartOf":{"@id":"https:\/\/celonpharma.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/celonpharma.com\/en\/faind\/#primaryimage"},"image":{"@id":"https:\/\/celonpharma.com\/en\/faind\/#primaryimage"},"thumbnailUrl":"https:\/\/celonpharma.com\/wp-content\/uploads\/2022\/10\/1178-106-max-1024x92.png","datePublished":"2018-01-05T11:41:33+00:00","dateModified":"2022-10-19T14:47:27+00:00","author":{"@id":"https:\/\/celonpharma.com\/en\/#\/schema\/person\/44c54386ed112173d6e8bcbeb6425338"},"breadcrumb":{"@id":"https:\/\/celonpharma.com\/en\/faind\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/celonpharma.com\/en\/faind\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/celonpharma.com\/en\/faind\/#primaryimage","url":"https:\/\/celonpharma.com\/wp-content\/uploads\/2022\/10\/1178-106-max-1024x92.png","contentUrl":"https:\/\/celonpharma.com\/wp-content\/uploads\/2022\/10\/1178-106-max-1024x92.png"},{"@type":"BreadcrumbList","@id":"https:\/\/celonpharma.com\/en\/faind\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/celonpharma.com\/en\/"},{"@type":"ListItem","position":2,"name":"FAIND"}]},{"@type":"WebSite","@id":"https:\/\/celonpharma.com\/en\/#website","url":"https:\/\/celonpharma.com\/en\/","name":"Celon Pharma","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/celonpharma.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/celonpharma.com\/en\/#\/schema\/person\/44c54386ed112173d6e8bcbeb6425338","name":"S\u0142awomir Ni\u017cnik"}]}},"_links":{"self":[{"href":"https:\/\/celonpharma.com\/en\/wp-json\/wp\/v2\/posts\/13728","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/celonpharma.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/celonpharma.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/celonpharma.com\/en\/wp-json\/wp\/v2\/users\/11"}],"replies":[{"embeddable":true,"href":"https:\/\/celonpharma.com\/en\/wp-json\/wp\/v2\/comments?post=13728"}],"version-history":[{"count":2,"href":"https:\/\/celonpharma.com\/en\/wp-json\/wp\/v2\/posts\/13728\/revisions"}],"predecessor-version":[{"id":26427,"href":"https:\/\/celonpharma.com\/en\/wp-json\/wp\/v2\/posts\/13728\/revisions\/26427"}],"wp:attachment":[{"href":"https:\/\/celonpharma.com\/en\/wp-json\/wp\/v2\/media?parent=13728"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/celonpharma.com\/en\/wp-json\/wp\/v2\/categories?post=13728"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/celonpharma.com\/en\/wp-json\/wp\/v2\/tags?post=13728"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}